These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7821305)

  • 1. Haemostatic factors and prevalent coronary heart disease; the FINRISK Haemostasis Study.
    Salomaa V; Rasi V; Pekkanen J; Vahtera E; Jauhiainen M; Vartiainen E; Myllylä G; Ehnholm C
    Eur Heart J; 1994 Oct; 15(10):1293-9. PubMed ID: 7821305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemostatic factors and lipoprotein (a) in three geographical areas in Finland: the Finrisk Haemostasis Study.
    Salomaa VV; Rasi VP; Vahtera EM; Pekkanen J; Pursiainen M; Jauhiainen M; Vartiainen E; Ehnholm CP; Myllylä G
    J Cardiovasc Risk; 1994 Oct; 1(3):241-8. PubMed ID: 7621304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemostatic factors as predictors of coronary events and total mortality: The FINRISK '92 Hemostasis Study.
    Salomaa V; Rasi V; Kulathinal S; Vahtera E; Jauhiainen M; Ehnholm C; Pekkanen J
    Arterioscler Thromb Vasc Biol; 2002 Feb; 22(2):353-8. PubMed ID: 11834541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of fibrinogen and lipoprotein(a) as a coronary heart disease risk factor in men (The Quebec Cardiovascular Study).
    Cantin B; Després JP; Lamarche B; Moorjani S; Lupien PJ; Bogaty P; Bergeron J; Dagenais GR
    Am J Cardiol; 2002 Mar; 89(6):662-6. PubMed ID: 11897206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remnant Lipoprotein Cholesterol and Incident Coronary Heart Disease: The Jackson Heart and Framingham Offspring Cohort Studies.
    Joshi PH; Khokhar AA; Massaro JM; Lirette ST; Griswold ME; Martin SS; Blaha MJ; Kulkarni KR; Correa A; D'Agostino RB; Jones SR; Toth PP;
    J Am Heart Assoc; 2016 Apr; 5(5):. PubMed ID: 27130348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coagulation factor VII and the risk of coronary heart disease in healthy men.
    Junker R; Heinrich J; Schulte H; van de Loo J; Assmann G
    Arterioscler Thromb Vasc Biol; 1997 Aug; 17(8):1539-44. PubMed ID: 9301633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein(a)-cholesterol and coronary heart disease in the Framingham Heart Study.
    Seman LJ; DeLuca C; Jenner JL; Cupples LA; McNamara JR; Wilson PW; Castelli WP; Ordovas JM; Schaefer EJ
    Clin Chem; 1999 Jul; 45(7):1039-46. PubMed ID: 10388480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lipoprotein (a) in a population-based study: more significant in Turkish women than men?].
    Onat A; Yazici M; Hergenç G; Doğan Y; Karabulut A; Sari I; Türkmen S; Can G; Sansoy V
    Anadolu Kardiyol Derg; 2005 Dec; 5(4):271-7. PubMed ID: 16330391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction--the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction.
    Scarabin PY; Aillaud MF; Amouyel P; Evans A; Luc G; Ferrières J; Arveiler D; Juhan-Vague I
    Thromb Haemost; 1998 Nov; 80(5):749-56. PubMed ID: 9843166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of c-reactive protein, serum amyloid a and fibrinogen with prevalent coronary heart disease--baseline findings of the PAIS project.
    Jousilahti P; Salomaa V; Rasi V; Vahtera E; Palosuo T
    Atherosclerosis; 2001 Jun; 156(2):451-6. PubMed ID: 11395043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender and employment grade differences in blood cholesterol, apolipoproteins and haemostatic factors in the Whitehall II study.
    Brunner EJ; Marmot MG; White IR; O'Brien JR; Etherington MD; Slavin BM; Kearney EM; Smith GD
    Atherosclerosis; 1993 Sep; 102(2):195-207. PubMed ID: 8251006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased activation of the haemostatic system in men at high risk of fatal coronary heart disease.
    Miller GJ; Bauer KA; Barzegar S; Cooper JA; Rosenberg RD
    Thromb Haemost; 1996 May; 75(5):767-71. PubMed ID: 8725721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Joint effect of high-density lipoprotein cholesterol and low-density lipoprotein cholesterol on the risk of coronary heart disease.
    Hu G; Cui Y; Jousilahti P; Sundvall J; Girman CJ; Antikainen R; Laatikainen T; Tuomilehto J
    Eur J Prev Cardiol; 2013 Feb; 20(1):89-97. PubMed ID: 22023802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor VII and fibrinogen levels examined by age, sex, and other atherosclerotic risk factors in a Japanese population. The Jichi Medical School Cohort Study.
    Ishikawa S; Kario K; Nago N; Kayaba K; Hiraoka J; Matsuo H; Goto T; Miyamoto T; Tsutsumi A; Nakamura Y; Shimada K; Inoue K; Igarashi M
    Thromb Haemost; 1997 May; 77(5):890-3. PubMed ID: 9184398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central obesity, insulin resistance, syndrome X, lipoprotein(a), and cardiovascular risk in Indians, Malays, and Chinese in Singapore.
    Hughes K; Aw TC; Kuperan P; Choo M
    J Epidemiol Community Health; 1997 Aug; 51(4):394-9. PubMed ID: 9328546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin resistance, haemostatic and inflammatory markers and coronary heart disease risk factors in Type 2 diabetic men with and without coronary heart disease.
    Wannamethee SG; Lowe GD; Shaper AG; Rumley A; Lennon L; Whincup PH
    Diabetologia; 2004 Sep; 47(9):1557-65. PubMed ID: 15365613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein(a) is not associated with coronary heart disease in the elderly: cross-sectional data from the Dubbo study.
    Simons L; Friedlander Y; Simons J; McCallum J
    Atherosclerosis; 1993 Feb; 99(1):87-95. PubMed ID: 8461064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-reactive protein and coronary heart disease in western Turkey.
    Onat A; Sansoy V; Yildirim B; Keleş I; Uysal O; Hergenç G
    Am J Cardiol; 2001 Sep; 88(6):601-7. PubMed ID: 11564380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men.
    Heinrich J; Balleisen L; Schulte H; Assmann G; van de Loo J
    Arterioscler Thromb; 1994 Jan; 14(1):54-9. PubMed ID: 8274478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of transdermal estradiol in combination with oral norethisterone on lipoproteins, coagulation, and endothelial markers in postmenopausal women with type 2 diabetes: a randomized, placebo-controlled study.
    Perera M; Sattar N; Petrie JR; Hillier C; Small M; Connell JM; Lowe GD; Lumsden MA
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1140-3. PubMed ID: 11238498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.